Clinical Trials Browser

Phase 1 × Not yet recruiting × glofitamab × Clear all

NCT07444710 2026-05-13

Testing the Addition of an Anti-Cancer Drug, Glofitamab, to the Usual Chemotherapy Treatment (Alternating R-CHOP/R-DHAP) for Previously Untreated Mantle Cell Lymphoma

Phase 1 Not yet recruiting

Ann Arbor Stage II Mantle Cell Lymphoma

NCT07528352 2026-04-17

REBEL

Phase 1 Not yet recruiting

Lymphoma, Large B-Cell, Diffuse